Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel disease
about
Inflammatory Bowel Disease (IBD) pharmacotherapy and the risk of serious infection: a systematic review and network meta-analysisNovel treatments for inflammatory bowel disease.Changing treatment paradigms for the management of inflammatory bowel disease.Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management.Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management.Incidence of Active Tuberculosis within One Year after Tumor Necrosis Factor Inhibitor Treatment according to Latent Tuberculosis Infection Status in Patients with Inflammatory Bowel Disease
P2860
Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel disease
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Clinical features of active tu ...... ith inflammatory bowel disease
@en
type
label
Clinical features of active tu ...... ith inflammatory bowel disease
@en
prefLabel
Clinical features of active tu ...... ith inflammatory bowel disease
@en
P2093
P2860
P356
P1433
P1476
Clinical features of active tu ...... ith inflammatory bowel disease
@en
P2093
Ja Seol Koo
Jang Wook Lee
Jeong Wook Kim
Ji Hoon Park
Sae Kyung Chang
Sang Bum Kang
You Sun Kim
Young Eun Joo
Young-Ho Kim
P2860
P304
P356
10.5217/IR.2016.14.2.146
P577
2016-04-27T00:00:00Z